Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 4 (2016) HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE Abstract  similar documents
M. R. Nodel
"... the role of circadian mechanisms in the manifestation of insomnia and hypersomnia in PD patients ..."
 
Vol 4, No 1 (2012) Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..."
 
Vol 13, No 2 (2021) Drug-induced hypersomnia Abstract  PDF (Eng)  similar documents
T. M. Ostroumova, O. D. Ostroumova, A. V. Filippova, T. F. Guseva
"... and develop due to abuse  and/or discontinuation of various medications. Drug- induced hypersomnia (DIH ..."
 
Vol 9, No 3 (2017) Clinical and psychopathological features of depressions with panic attacks Abstract  similar documents
N. N. Ivanets, K. M. Tartynsky, G. L. Krenkel, S. V. Prokhorova
"... with panic attacks were inherent in melancholic and dreary symptoms, anhedonia, classical circadian mood ..."
 
Vol 9, No 4 (2017) Sleep disorders in Parkinson’s disease: approaches to treatment and prevention Abstract  similar documents
M. R. Nodel, G. V. Kovrov
"... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..."
 
Vol 12, No 6 (2020) Atypical depression in bipolar affective disorder: a clinical case study Abstract  similar documents
M. S. Verbitskaya, N. A. Tyuvina, G. L. Krenkel, E. N. Efremova, A. E. Stolyarova
"... : hyperphagia, hypersomnia, lead-palsy, and personality sensitivity. AtD has been described within a variety ..."
 
Vol 14, No 5 (2022) Clinical and genetic associations of the CLOCK circadian rhythm gene and depressive disorders in patients with alcohol dependence syndrome during the period of alcohol abstinence Abstract  PDF (Eng)  similar documents
N. R. Tulbaeva, R. F. Nasyrova, D. A. Smirnova, Z. Sh. Ashurov, I. S. Efremov, V. S. Dobrodeeva, A. E. Abdrakhmanova, A. R. Asadullin
"... clinical and genetic associations of the CLOCK circadian rhythm gene and depressive disorders during ..."
 
Vol 15, No 3 (2023) Association of the circadian rhythm gene ARNTL/BMAL1 with personal anxiety among people aged 25–64 (WHO international program “MONICA-psychosocial (MOPSY)”) Abstract  PDF (Eng)  similar documents
V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, А. V. Gafarova
 
Vol 12, No 5 (2020) On the heterogeneity of depression in Parkinson’s disease Abstract  similar documents
M. R. Nodel, N. N. Yakhno
"... Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..."
 
Vol 5, No 1 (2013) Dopamine dysregulation syndrome in Parkinson’s disease Abstract  similar documents
A V Nikitina, Natalia Vladimirovna Fedorova
"... therapy. According to the data available in the literature, DDS develops in 3-4% of the Parkinson’s ..."
 
Vol 15, No 3 (2023) Parkinson’s disease. Focus on early stages Abstract  similar documents
E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova
"... in the early stages of Parkinson’s disease (PD) and considers the hypothesis of the presence of body-first ..."
 
Vol 6, No 4 (2014) The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) Abstract  similar documents
M. R. Sapronova, N. A. Shnaider
"... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..."
 
Vol 5, No 2 (2013) Current possibilities of therapy for sleep disorders in Parkinson’s disease Abstract  similar documents
Marina Romanovna Nodel
"... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..."
 
Vol 16, No 3 (2024) Treatment of the early stages of Parkinson's disease. Differences in approaches to the choice of therapy in different countries Abstract  similar documents
E. V. Bril, N. V. Fedorova, T. K. Kulua, O. S. Zimnyakova
"... The review addresses an approach to the treatment of early stages of Parkinson's disease (PD ..."
 
Vol 9, No 4 (2017) Neuropsychological pattern of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova
"... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..."
 
Vol 9, No 1 (2017) The genetic basis of Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova
"... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..."
 
Vol 2, No 4 (2010) Depression in Parkinson's disease Abstract  similar documents
M. R. Nodel'
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..."
 
Vol 6, No 1 (2014) Apathy in Parkinson's disease patients Abstract  similar documents
M. R. Nodel
"... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..."
 
Vol 3, No 1 (2011) Sleep disorders in Parkinson's disease Abstract  similar documents
M. R. Nodel
"... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients ..."
 
Vol 17, No 3 (2025) Parkinson's disease and migraine Abstract  similar documents
Z. A. Zalyalova, E. A. Katunina, D. V. Pokhabov
"... Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Migraine ..."
 
Online-first Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..."
 
Vol 11, No 2 (2019) Pathogenesis, clinical features, and treatments of depression in Parkinson's disease Abstract  similar documents
I. V. Milyukhina
"... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..."
 
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
M. R. Nodel
"... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..."
 
Vol 6, No 4 (2014) Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease Abstract  similar documents
V. L. Golubev, A. B. Kamakinova
"... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..."
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
 
Vol 15, No 3 (2023) Vitamin B12 deficiency and Parkinson’s disease Abstract  similar documents
Z. A. Zalyalova, E. V. Ekusheva
"... Parkinson’s disease (PD) is a progressive neurodegenerative disease with various clinical ..."
 
Vol 17, No 3 (2025) Autonomic cardiovascular dysregulation and other non-motor manifestations of Parkinson’s disease Abstract  similar documents
A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov
"... Most patients with Parkinson’s disease (PD) experience autonomic cardiovascular dysfunction ..."
 
Vol 7, No 2 (2015) Gender features of depressive disorders in women Abstract  similar documents
N. A. Tyuvina, V. V. Balabanova, E. O. Voronina
"... , fatigue, increased appetite, weight gain, hypersomnia, and signs of somatization), as well as rarer ..."
 
Vol 4, No 2 (2012) Sleep and memory problems: acetylcholine in some neurodegenerative diseases, use of an extended-release formulation of galantamine Abstract  similar documents
I V Litvinenko
"... and acetylcholine (AC) levels. Moderate impairments of circadian rhythms can develop with aging; however ..."
 
Vol 2, No 3 (2010) Treatment of parkinson's disease at a young age Abstract  similar documents
D. V. Artemyev
"... and middle-aged patients. It is stressed that early-onset Parkinson's disease (PD) shows a number ..."
 
Vol 1, No 2 (2009) NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE Abstract  similar documents
M. R. Nodel', N. N. Yakhno
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..."
 
Vol 14, No 1 (2022) Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease Abstract  similar documents
D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh
"... Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. Consequently, there has ..."
 
Vol 5, No 2 (2013) Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures Abstract  similar documents
Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov
"... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..."
 
Vol 5, No 2 (2013) The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms Abstract  similar documents
E N Gubanova, Natalia Vladimirovna Fedorova
"... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..."
 
Vol 5, No 1 (2013) Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease Abstract  similar documents
Oleg Semenovich Levin, V K Datiyeva
"... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..."
 
Vol 12, No 5 (2020) The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease Abstract  similar documents
I. V. Miliukhina
"... Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which ..."
 
Vol 9, No 1 (2017) The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease Abstract  similar documents
G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov
"... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..."
 
Vol 7, No 3 (2015) Experience with sustained-release melatonin for the treatment of sleep disorders in depression Abstract  similar documents
Svetlana Vladimirovna Prokhorova, T. N. Maksimova
"... The data available in the literature on the role of melatonin in the regulation of circadian ..."
 
Vol 14, No 4 (2022) Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease Abstract  similar documents
E. V. Yakovenko, F. A. Abbasov
"... Mental and cognitive impairments are common non-motor symptoms of Parkinson's disease (PD), which ..."
 
Vol 15, No 1 (2023) The gut microbiome as a factor in the development of Parkinson's disease Abstract  similar documents
L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov
"... Parkinson's disease (PD) is a neurodegenerative disease characterized by the progressive death ..."
 
Vol 12, No 1 (2020) Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova
"... Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable ..."
 
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in early ..."
 
Vol 15, No 6 (2023) Effect of dopaminergic therapy on lacrimation in Parkinson's disease Abstract  similar documents
A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk
"... The prevalence of dry eye syndrome (DES) in Parkinson's disease (PD) reaches 87% and leads ..."
 
Vol 15, No 3 (2023) Mental disorders during the pandemic of a new coronavirus infection: clinical features Abstract  similar documents
V. A. Vysokova, N. A. Tyuvina, T. N. Maksimova, S. V. Prokhorova
"... , severe apathy, hypersomnia and lack of sleep, fatigue, increased appetite, and complaints of impaired ..."
 
Vol 13, No 6 (2021) Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease Abstract  similar documents
E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova
"... . Patients and methods. The study included 75 patients with Parkinson's disease (PD): 49 (65.3%) women and 26 ..."
 
Vol 7, No 3 (2015) Experience in using levodopa-benserazide Abstract  similar documents
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova
"... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..."
 
Vol 9, No 3 (2017) Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale Abstract  similar documents
A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova
"... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..."
 
Vol 16, No 2 (2024) Efficacy of antiparkinsonian therapy in tremor correction according to tremorography Abstract  similar documents
V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov
"... the frequency-amplitude characteristics in the correction of tremulous hyperkinesis in Parkinson's disease (PD ..."
 
Vol 14, No 6 (2022) A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study Abstract  similar documents
Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova
"... effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine ..."
 
Vol 12, No 6 (2020) Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease Abstract  similar documents
I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova
"... Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity ..."
 
Vol 3, No 3 (2011) ICD-10 and the clinical features of depressions: data of the CIRCADIAN-I program Abstract  similar documents
O. V. Serdyuk, A. A. Ovchinnikov, N. A. Kutuzova, M. Yu. Drobizhev, K. Yu. Retyunsky
"... The data of the CIRCADIAN-I trial suggest that depressions are unsatisfactorily diagnosed ..."
 
Vol 11, No 3 (2019) The features of the pathogenesis and clinical picture of Parkinson's disease that has developed in essential tremor Abstract  similar documents
A. V. Kudrevatykh, I. V. Miliukhina
"... In the past decades, there has been evidence on the relationship between Parkinson's disease (PD ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
 
Vol 10, No 4 (2018) Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease Abstract  similar documents
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno
"... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..."
 
Vol 11, No 3 (2019) The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases Abstract  similar documents
I. V. Miliukhina
"... The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper ..."
 
Vol 3, No 3 (2011) Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) Abstract  similar documents
M. R. Nodel
"... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..."
 
Vol 10, No 4 (2018) Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease Abstract  similar documents
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova
"... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..."
 
Vol 3, No 1 (2011) Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease Abstract  similar documents
I. G. Tishkova, I. S. Preobrazhenskaya
"... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..."
 
Vol 16, No 4 (2024) Agomelatine: pharmacological profile, possible application, advantages Abstract  similar documents
V. E. Medvedev, O. V. Kotova, A. V. Palin, O. V. Mikheeva, E. S. Akarachkova
"... agonist. Through its effect on melatonin receptors, agomelatine resynchronizes disturbed circadian rhythms ..."
 
Vol 11, No 2 (2019) Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease Abstract  similar documents
A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko
"... Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated ..."
 
Vol 3, No 4 (2011) Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease Abstract  similar documents
M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev
"... ) in 70 patients (28 men and 42 women) with Parkinson's disease (PD), by using the examination protocol ..."
 
Vol 16, No 3 (2024) Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem) Abstract  similar documents
Kh. I. Alizade, A. A. Ragimova, E. Yu. Fedotova, S. N. Illarioshkin
"... Psychotic disorders in Parkinson's disease (PD) are common non-motor manifestations that have ..."
 
Vol 16, No 6 (2024) Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy Abstract  similar documents
D. V. Zakharov, D. D. Kokareva
"... of Parkinson's disease at all stages of the disease. They impair the patient's quality of life and ability ..."
 
Vol 13, No 4 (2021) Treatment of antipsychotic-induced parkinsonism in schizophrenic patients Abstract  similar documents
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova
 
Vol 10, No 3 (2018) Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis Abstract  PDF (Eng)  similar documents
T. K. Davydova, A. A. Tappakhov, T. E. Popova, E. E. Konnikova, A. D. Alekseeva, D. A. Popov
"... siblings, one of whom is observed to have parkinsonism with ALS syndrome; and the other had Parkinson ..."
 
Vol 13, No 5 (2021) Association of polymorphic variants of genes (HTR2A, MTNR1A, MTNR1B, CLOCK, DRD2) and insomnia in alcohol dependence syndrome Abstract  PDF (Eng)  similar documents
I. S. Efremov, A. R. Asadullin, V. S. Dobrodeeva, N. A. Shnayder, E. A. Akhmetova, D. R. Tukhvatullina, E. M. Krupitsky, R. F. Nasyrova
"... studies on the role of genetic polymorphism of circadian rhythm regulators in sleep disorders in patients ..."
 
1 - 70 of 82 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)